Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.